Roche Morocco is proud to announce the appointment of Dr. Anis EL MEKAOUI as its new General Manager. In his new role, he will focus on advancing innovative healthcare solutions, strengthening strategic partnerships, and supporting the transformation of Morocco’s healthcare system to benefit patients. He succeeds Dr. Sanaa Sayagh, who was recently appointed to a leadership position at Roche in Indonesia.
With over 20 years of experience in the pharmaceutical industry, Dr. EL MEKAOUI has recognized expertise in commercial strategy, sales, marketing, and medical affairs, acquired across various regions, including North Africa, the Middle East, and Central and Eastern Europe. A trained physician, he also holds a Master’s in Biopharmaceutical Management from the École Supérieure de Commerce de Paris (ESCP-EAP, Paris).
At Roche Morocco, he has held key positions such as Director of Sales and Marketing and Director of Commercial Operations. In these roles, he has led strategic initiatives aimed at optimizing treatment access and accelerating healthcare innovation in Morocco. In addition to his new responsibilities, Dr. EL MEKAOUI is also the President of the Association Les Entreprises du Médicament au Maroc (LEMM), demonstrating his commitment to advancing the pharmaceutical sector in Morocco and fostering collaboration across the healthcare ecosystem.
Strengthened Leadership for a Lasting Impact
Maturin Tchoumi, Head of Africa, Pharma at Roche, welcomed this appointment:
“We are delighted to have Dr. Anis EL MEKAOUI leading Roche Morocco. His experience and strategic vision will be valuable assets in furthering our commitment to Moroccan patients. He will play an active role in Roche Morocco’s growth, innovation, and the strengthening of partnerships to maximize our impact on healthcare. This appointment reflects our dedication to investing in local talent and empowering them in high-value leadership roles.”
Ms. Silvia Barceleiro, Cluster Head , Pharma International at Roche, added:
“Dr. Anis EL MEKAOUI brings an in-depth understanding of the Moroccan healthcare ecosystem and proven expertise in implementing innovative solutions and fostering collaboration. As Roche continues its commitment to building sustainable healthcare systems, his leadership will be instrumental in addressing current and future challenges.”
Upon assuming his new role, Dr. EL MEKAOUI reaffirmed his commitment:
“It is a great honor to lead Roche Morocco. Morocco plays a central role in Roche’s strategy, and I am determined to strengthen our leadership in the biopharmaceutical sector while expanding access to innovative therapies for Moroccan patients.”
An Appointment Aligned with Roche’s Mission
This transition reflects Roche Morocco’s mission to provide innovative healthcare solutions while ensuring equitable access to care. It also aligns with Roche’s broader commitment to transforming healthcare both globally and locally.
About Roche
Founded in 1896 in Basel, Switzerland, Roche was one of the first industrial manufacturers of branded medicines. It has since grown into the world’s largest biotechnology company and a global leader in in-vitro diagnostics. Roche pursues scientific excellence to discover and develop medicines and diagnostics that improve and save lives worldwide. A pioneer in personalized healthcare, Roche is committed to transforming the delivery of healthcare for even greater impact.
For over 125 years, sustainability has been integral to Roche’s operations. As a science-driven company, its greatest contribution to society is developing innovative medicines and diagnostics that help people live healthier lives. Roche is committed to initiatives like the Science Based Targets Initiative and the Sustainable Markets Initiative to achieve net-zero emissions by 2045.
Roche Morocco
With a presence in Morocco spanning over 60 years, Roche Morocco has established itself as a leader in healthcare, specializing in oncology, hematology, neuroscience, hemophilia, and ophthalmology. As part of the F. Hoffmann-La Roche Group, Roche Morocco combines global expertise with local insights to provide holistic care and innovative disease management solutions.
Roche Morocco collaborates with local institutions, NGOs, and the government to develop sustainable healthcare solutions tailored to the Moroccan context. The company has spearheaded transformative access programs, particularly in oncology, and continues to enhance the nation’s healthcare infrastructure and technology transfer.